YBX1 and central nervous system cancer: Notably, in contrast to a previous report in glioma cells [26], we saw a significant increase rather than decrease in MDM2 mRNA following YB-1 knockdown in both MSTO-211H and VMC23 cells, while REN cells showed no significant change.